{"OMIM ID": "OMIM:616341", "DISEASE": "Epileptic Encephalopathy, Early Infantile, 30", "RECORD": "Rare disease patients have complex clinical representations. Patients with Epileptic Encephalopathy, Early Infantile, 30 present clinical features that include epilepsy, intellectual disability, and developmental delay. The disease is caused by mutations in the KCNQ2 gene, which encodes the Kv7.2 voltage-gated potassium channel.\n\nThe drug is a potassium channel opener that is designed to treat patients with epilepsy and intellectual disability. The drug is being. Some special cases also present a.\n\nEpileptic Encephalopathy, Early Infantile, 30 (EE30) is a rare genetic disorder that causes epilepsy, intellectual disability, and developmental delay. The disease is caused by mutations in the KCNQ2 gene, which encodes the Kv7.2 voltage-gated potassium channel.\n\nThe drug is a potassium channel opener that is designed to treat patients with epilepsy and intellectual disability. The drug is being. Some special cases also present a.\n\nEpileptic Encephalopathy, Early Infantile, 30 (EE30) is a rare genetic disorder that causes. The main symptomatic differences of Epileptic Encephalopathy, Early Infantile, 30 from similar diseases is that the patients present with.\n\nEpileptic Encephalopathy, Early Infantile, 30 (EE30) is a rare genetic disorder that causes epilepsy, intellectual disability, and developmental delay. The disease is caused by mutations in the KCNQ2 gene, which encodes the Kv7.2", "SUMMARY": " voltage-gated potassium channel.\n\nThe drug is a potassium channel opener that is designed to treat patients with epilepsy and intellectual disability. The drug is being. Some special cases also present a.\n\nEpileptic Encephalopathy,"}